Finance

Lists
Why is 603087 down 2,85%?
Dive Deeper
603087:SHA
Gan & Lee Pharmaceuticals
67,82 CN¥
-2,85%
(-1,99) 1D
19 հոկ, 11:29:58 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603087...
Open
69,50 CN¥
High
70,83 CN¥
Low
67,65 CN¥
Mkt. cap
41,71 մլրդ
Avg. vol.
7,72 մլն
Volume
5,28 մլն
Dividend
1,47%
Quarterly dividend
0,25 CN¥
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
35,04
52-wk high
79,99 CN¥
52-wk low
51,51 CN¥
EPS
1,94 CN¥
No. of employees
5 հզր
Open
69,50 CN¥
High
70,83 CN¥
Low
67,65 CN¥
Mkt. cap
41,71 մլրդ
Avg. vol.
7,72 մլն
Volume
5,28 մլն
Dividend
1,47%
Quarterly dividend
0,25 CN¥
Ex-dividend date
29 մյս, 2026 թ.
P/E ratio
35,04
52-wk high
79,99 CN¥
52-wk low
51,51 CN¥
EPS
1,94 CN¥
No. of employees
5 հզր
News stories
From web sources and news partners
About Gan & Lee Pharmaceuticals
CEO-
Employees5,31 հզր
Founded17 հնս, 1998 թ.
Headquarters-
Sector-
Websiteganlee.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
980,24 մլն
1,01 մլրդ
878,11 մլն
1,34 մլրդ
Cost of goods sold
234,89 մլն
259,72 մլն
223,40 մլն
359,10 մլն
Cost of revenue
234,89 մլն
259,72 մլն
223,40 մլն
359,10 մլն
Research and development expenses
143,34 մլն
239,11 մլն
128,04 մլն
170,06 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
384,60 մլն
444,21 մլն
327,25 մլն
377,07 մլն
Operating expense
527,76 մլն
709,00 մլն
462,53 մլն
557,24 մլն
Total operating expenses
762,65 մլն
968,72 մլն
685,94 մլն
916,35 մլն
Operating income
217,59 մլն
36,39 մլն
192,17 մլն
428,57 մլն
Other non operating income
56,64 մլն
-70,56 մլն
-1,12 մլն
3,22 մլն
EBT including unusual items
234,69 մլն
304,10 մլն
212,64 մլն
474,46 մլն
EBT excluding unusual items
290,23 մլն
257,75 մլն
205,87 մլն
465,75 մլն
Income tax expense
20,03 մլն
-21,15 մլն
20,18 մլն
57,59 մլն
Effective tax rate
8,53%
-6,95%
9,49%
12,14%
Other operating expenses
-209,47 հզր
25,46 մլն
7,75 մլն
9,04 մլն
Net income
214,66 մլն
325,24 մլն
192,49 մլն
417,29 մլն
Net profit margin
21,90%
32,36%
21,92%
31,03%
Earnings per share
-
-
-
-
Interest and investment income
16,11 մլն
303,56 մլն
14,82 մլն
55,17 մլն
Interest expense
-
-231,14 հզր
-
-102,21 հզր
Net interest expenses
16,11 մլն
303,33 մլն
14,82 մլն
55,07 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
280,34 մլն
110,65 մլն
266,44 մլն
519,60 մլն
Gain or loss from assets sale
-
-3,71 մլն
-
54,15 հզր
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google Apps